Similarly, Huang et al. [67] found that the necroptosis-related gene H2BC18 significantly impacts the progression and immune environment of colorectal cancer, with their developed prognostic model predicting CRC outcomes effectively, suggesting that targeting H2BC18 could improve immunotherapy precision and treatment customization. Here, H2BC18 is linked to colorectal cancer.